Foreword
At the Kolling, we are supported by a joint-venture partnership between the Northern Sydney Local Health District and the University of Sydney. The partnership enables us to conduct biomedical and clinical research to discover, innovate, and implement our findings into healthcare delivery.
As we embark on the 2026-2030 strategic period, our aim is to build upon our historic strengths, refining and enhancing them to meet the health and planetary challenges of the present and into the future. This plan outlines our direction for the next five years, including the strategic decision to establish cancer as our fourth key research focus, in addition to our existing research areas of:
We then systematically identified the actions and initiatives needed to align our trajectory for the next five years with this long-term vision, ensuring we were well-positioned to achieve our ambitious goals of implementing our impactful research for generations to come. We confirmed our goals would aim to execute the discovery, innovation and implementation cycle of our research findings, enabled by and with focused objectives to strengthen community partnerships, increase our collaborations, and improve our sustainability. Significant time was dedicated to articulating our guiding beliefs and central aims. As clinicians, researchers, educators, and scientists, we are acutely aware that our work often intersects with individuals in their most vulnerable moments. While we strive for positive outcomes, we also recognise that survival alone does not guarantee that people will truly flourish in life after an injury or a diagnosis of illness. This underscores the strategy’s focus, with the aim of patient centred thriving and wellbeing. Adopting cancer as our fourth focus area of research will enable the Kolling to further its aim of addressing the complex challenges of long-term patient wellbeing. We look forward to working with our researchers, clinicians and the community over the next five years as we drive innovative and translational research that makes a real difference to the health and wellbeing of the community.
» cardiovascular, renal, and metabolic » musculoskeletal and rehabilitation » sensory, neuroscience, ageing, pain, and psychiatry.
The Kolling is home to several recognised global leaders in cancer research, and we will draw on this strength to foster innovative research that can be translated into real-world outcomes that improve cancer treatments and survival, not just across our district but nationally and worldwide. This forward-looking strategy was developed by engaging a broad spectrum of stakeholders, including patients and those with lived experience, clinicians, researchers, scientists, administrators, and industry partners. Given our rich history in biomedical discovery, we challenged stakeholders to envision an ideal future state of discovery, innovation, and implementation. This process began with defining our core strengths, identifying the enduring attributes that have defined our excellence over the past century, before producing an ambitious vision for the next 100 years.
Michael Nugent Governance Committee Chair
Professor James Elliott Academic Director
Made with FlippingBook - professional solution for displaying marketing and sales documents online